Sign In
Buy GLPG
$27.38
+0.0650 (+0.238%)
At Close: Jun 03, 2026
Is Galapagos (GLPG) Stock Outpacing Its Medical Peers This Year?
11:18am, Thursday, 02'nd Jun 2022
Here is how Galapagos NV (GLPG) and Patterson Cos. (PDCO) have performed compared to their sector so far this year.
Galapagos: Can The Company Turn Around?
01:18pm, Thursday, 19'th May 2022
Amid the biotech bear market, there are companies that are trading on a deep bargain, yet you should be extremely careful before averaging down. Though I noticed the fundamental changes in Galapagos,
Is Galapagos (GLPG) Outperforming Other Medical Stocks This Year?
01:40pm, Monday, 16'th May 2022 Zacks Investment Research
Here is how Galapagos NV (GLPG) and Halozyme Therapeutics (HALO) have performed compared to their sector so far this year.
Is Galapagos (GLPG) Outperforming Other Medical Stocks This Year?
11:17am, Monday, 16'th May 2022
Here is how Galapagos NV (GLPG) and Halozyme Therapeutics (HALO) have performed compared to their sector so far this year.
Perrigo (PRGO) Q1 Earnings Miss, Margins Hurt by Higher Costs
01:47pm, Wednesday, 11'th May 2022 Zacks Investment Research
Perrigo (PRGO) reports mixed first-quarter 2022 results. Sales of cough/cold products continue the strong rebound during the reported quarter. Costs headwinds offset volume and price growth.
RBC Expects Business Development To Unlock This Pharma Stock's Balance Sheet Value
07:30pm, Monday, 09'th May 2022 Benzinga
RBC Capital Markets views Galapagos' NV (NASDAQ: GLPG) Q1 Jyseleca revenues in line as the story focuses on whether new leadership can unlock value from GLPG's ample balance sheet.
Jyseleca's Q1 s
Galapagos creëert nieuwe inschrijvingsrechtenplannen
08:01pm, Friday, 06'th May 2022 GlobeNewswire Inc.
Mechelen, België; 6 mei 2022, 22.01 CET; gereglementeerde informatie –– Galapagos NV (Euronext & NASDAQ: GLPG) kondigt vandaag aan dat haar raad van bestuur 2.326.025 inschrijvingsrechten heeft
Galapagos creates new subscription right plans
08:01pm, Friday, 06'th May 2022 GlobeNewswire Inc.
Mechelen, Belgium; 6 May 2022, 22.01 CET; regulated information –– Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its board of directors created 2,326,025 subscription rights under n
Galapagos NV (GLPG) CEO Paul Stoffels on Q1 2022 Results - Earnings Call Transcript
12:16pm, Friday, 06'th May 2022
Galapagos NV (NASDAQ:GLPG ) Q1 2022 Results Conference Call May 6, 2022 8:00 AM ET Company Participants Sofie Van Gijsel - Senior Director, Investor Relations Paul Stoffels - Chief Executive Officer B
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
12:43pm, Thursday, 05'th May 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
FDA Approval For AstraZeneca-Daiichi's Enhertu Expands To Earlier Use In Metastatic Breast Cancer
The�
Has Galapagos (GLPG) Outpaced Other Medical Stocks This Year?
01:40pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Here is how Galapagos NV (GLPG) and MedAvail Holdings, Inc. (MDVL) have performed compared to their sector so far this year.
Has Galapagos (GLPG) Outpaced Other Medical Stocks This Year?
11:21am, Thursday, 28'th Apr 2022
Here is how Galapagos NV (GLPG) and MedAvail Holdings, Inc. (MDVL) have performed compared to their sector so far this year.
Strength Seen in Galapagos NV (GLPG): Can Its 5% Jump Turn into More Strength?
01:10pm, Monday, 04'th Apr 2022 Zacks Investment Research
Galapagos NV (GLPG) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down th
Strength Seen in Galapagos NV (GLPG): Can Its 5% Jump Turn into More Strength?
10:33am, Monday, 04'th Apr 2022
Galapagos NV (GLPG) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down th
Hurtigruten Grows Expedition Cruises, Doubles 2023 Galapagos Sailings With New Partner
09:45pm, Saturday, 02'nd Apr 2022
Daniel Skjeldam, CEO of Hurtigruten Group, talks about why now is the right time to expand its portfolio of destinations and ships. He also shares the organization's deep focus on more sustainable and
